These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 8304758

  • 1. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma.
    Heald P, Yan SL, Edelson R.
    Arch Dermatol; 1994 Feb; 130(2):198-203. PubMed ID: 8304758
    [Abstract] [Full Text] [Related]

  • 2. Utility of flow cytometry immunophenotyping and DNA ploidy studies for diagnosis and characterization of blood involvement in CD4+ Sézary's syndrome.
    Lima M, Almeida J, dos Anjos Teixeira M, Queiros ML, Santos AH, Fonseca S, Balanzategui A, Justica B, Orfao A.
    Haematologica; 2003 Aug; 88(8):874-87. PubMed ID: 12935975
    [Abstract] [Full Text] [Related]

  • 3. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
    Vidulich KA, Talpur R, Bassett RL, Duvic M.
    Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
    [Abstract] [Full Text] [Related]

  • 4. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K, Yawalkar N, Jones D, Kupper TS.
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [Abstract] [Full Text] [Related]

  • 5. Blood and lymph node T lymphocytes in cutaneous T cell lymphoma: evaluation by light microscopy.
    Schechter GP, Bunn PA, Fischmann AB, Matthews MJ, Guccion J, Soehnlen F, Munson D, Minna JD.
    Cancer Treat Rep; 1979 Apr; 63(4):571-4. PubMed ID: 312694
    [Abstract] [Full Text] [Related]

  • 6. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
    Sokolowska-Wojdylo M, Wenzel J, Gaffal E, Lenz J, Speuser P, Erdmann S, Abuzahra F, Bowman E, Roszkiewicz J, Bieber T, Tüting T.
    Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
    [Abstract] [Full Text] [Related]

  • 7. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
    Morice WG, Katzmann JA, Pittelkow MR, el-Azhary RA, Gibson LE, Hanson CA.
    Am J Clin Pathol; 2006 Mar; 125(3):364-74. PubMed ID: 16613339
    [Abstract] [Full Text] [Related]

  • 8. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF, Bunn P, Mann D, Thomas C, Eisenbarth GS, Minna J, Fauci AS.
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [Abstract] [Full Text] [Related]

  • 9. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    Introcaso CE, Micaily B, Richardson SK, Junkins-Hopkins JM, Yoon JS, Kim EJ, Vittorio CC, Rook AH.
    J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
    [Abstract] [Full Text] [Related]

  • 10. Serum soluble interleukin 2 receptor levels in erythrodermic cutaneous T-cell lymphoma correlate with response to photopheresis-based treatment.
    Goldman BD, Oh SK, Davis BE, Kadin ME, Poiesz BJ, Koh HK.
    Arch Dermatol; 1993 Sep; 129(9):1166-70. PubMed ID: 8363402
    [Abstract] [Full Text] [Related]

  • 11. Quantitative flow cytometric identification of aberrant T cell clusters in erythrodermic cutaneous T cell lymphoma. Implications for staging and prognosis.
    Horna P, Deaver DM, Qin D, Moscinski LC, Sotomayor EM, Glass LF, Sokol L.
    J Clin Pathol; 2014 May; 67(5):431-6. PubMed ID: 24319102
    [Abstract] [Full Text] [Related]

  • 12. [Cutaneous lymphoma of the Sézary and Bouvrain type. Progress in physiopathologic and therapeutic outlook].
    Bagot M.
    Bull Acad Natl Med; 1998 May; 182(5):927-37; discussion 937-8. PubMed ID: 9735499
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Peripheral blood findings in erythrodermic patients: importance for the differential diagnosis of Sézary syndrome.
    Nagler AR, Samimi S, Schaffer A, Vittorio CC, Kim EJ, Rook AH.
    J Am Acad Dermatol; 2012 Mar; 66(3):503-8. PubMed ID: 22005074
    [Abstract] [Full Text] [Related]

  • 18. CD4(+)CD7(-) T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome.
    Rappl G, Muche JM, Abken H, Sterry W, Tilgen W, Ugurel S, Reinhold U.
    J Am Acad Dermatol; 2001 Mar; 44(3):456-61. PubMed ID: 11209115
    [Abstract] [Full Text] [Related]

  • 19. The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers.
    Klemke CD, Brade J, Weckesser S, Sachse MM, Booken N, Neumaier M, Goerdt S, Nebe TC.
    Br J Dermatol; 2008 Sep; 159(4):871-80. PubMed ID: 18652582
    [Abstract] [Full Text] [Related]

  • 20. Heterogeneity of circulating CD4+ memory T-cell subsets in erythrodermic patients: CD27 analysis can help to distinguish cutaneous T-cell lymphomas from inflammatory erythroderma.
    Fierro MT, Novelli M, Quaglino P, Comessatti A, Fava P, Ortoncelli M, Ponti R, Bernengo MG.
    Dermatology; 2008 Sep; 216(3):213-21. PubMed ID: 18182812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.